RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R2033207 | PF06835919 | Ketohexokinase inhibitor 1 is an inhibitor of ketohexokinase (KHK), with IC50s o |
| R2033208 | NTP-42 | NTP42 is a thromboxane A2 (TXA2) receptor antagonist with an IC50 of 3.278 nM fo |
| R2033209 | EN6 | EN6 is a small-molecule in vivo activator of autophagy that covalently targets c |
| R2033210 | CC-90011 benzenesulfonate | CC-90011 benzenesulfonate is a potent, selective, reversible and orally active i |
| R2033211 | CH7057288 | CH7057288 is a potent and selective TRK inhibitor. |
| R2033212 | Borussertib | Borussertib is a covalent-allosteric and first-in-class inhibitor of protein kin |
| R2033213 | ORM-15341 | ORM-15341 is a potent and full antagonist for human AR (hAR) with IC50 values of |
| R2033214 | CC115 | CC-115 is a potent and dual DNA-PK and mTOR kinase inhibitor with IC50s of 13 nM |
| R2033215 | ML327 | ML327 is a blocker of MYC which can also de-repress E-cadherin transcription and |
| R2033216 | CCMI | CCMI is a potent and selective α7 nAChR-positive allosteric modulator, does not |
| R2033217 | DS-1001b | DS-1001b is a mutant IDH-1 (Isocitrate Dehydrogenase-1) inhibitor extracted from |
| R2033218 | GSK3145095 | GSK3145095 is a RIP1 kinase inhibitor with an IC50 of 6.3 nM . |
| R2033219 | Marizomib | Marizomib (Salinosporamide A) is a second-generation, irreversible, brain-penetr |
| R2033220 | Cinaciguat | Cinaciguat is an activator of guanylate cyclase (sGC), and used for acute decomp |
| R2033221 | SJB2-043 | SJB2-043 is an inhibitor of the native USP1/UAF1 complex with IC50 of 544 nM. |
| R2033222 | PTC596 | PTC596 is an orally active and selective B-cell-specific Moloney murine leukemia |
| R2033223 | Glumetinib;SCC244 | Glumetinib (SCC244) is a potent and highly selective c-Met kinase inhibitor with |
| R2033224 | EC-5062;EC5026(BPN-19186) | EC5026 (BPN-19186) is a first-in-class, potent and orally active soluble Epoxide |
| R2033266 | Astemizole (R 43512) | Astemizole (R 43512), a second-generation antihistamine drug to diminish allergi |
| R2033267 | Oxaliplatin | Oxaliplatin is a DNA synthesis inhibitor. Oxaliplatin causes DNA cros |
| R2033268 | SU14813 | SU14813 is a multi-targeted receptor tyrosine kinases inhibitor with IC50s |
| R2033269 | Lifirafenib (BGB-283) | Lifirafenib (BGB-283) potently inhibits RAF family kinases and EG |
| R2033280 | Acoziborole (SCYX-7158) | Acoziborole (SCYX-7158) is an effective, safe and orally active treatment for hu |
| R2033281 | VU6015929 | VU6015929 is a potent, selective and orally active dual discoidin domain re |
| R2033282 | Vanin-1-IN-1 | Vanin-1-IN-1 is an inhibitor of vanin-1 enzyme which is a cell surface associate |
